Uncorrected acuity at 36 months showed continuous range: monocular 20/20 distance and intermediate, 20/27 near; binocular ...
George O. Waring IV, MD, FACS, discussed how “tolerance” may expand the QRS functional vision model, with new data on IOL ...
Johnson & Johnson will present data from two major studies supporting the performance of its recently FDA-approved TECNIS PureSee intraocular lens (IOL) at the 2026 American Society of Cataract and ...
P&I found pension funds ‘on the ropes’ in 2006 — NCPERS’ Hank Kim explains what’s changed for public plans ...
Detailed price information for Bausch Lomb Corporation (BLCO-T) from The Globe and Mail including charting and trades.
"Cataract surgeons naturally want to offer patients a little more — without trade-offs," said Terry Kim, M.D., Chief Medical Officer at Alcon. "Surgeons told us they were looking for an enhanced ...
Clareon TruPlus [Image from Alcon] Alcon (NYSE:ALC) announced today that it launched its Clareon TruPlus intraocular lens (IOL) technology in the U.S. The company launched its new, enhanced-design ...
The Tecnis PureSee non-toric IOL. [Image courtesy of Johnson & Johnson] The Vision business at Johnson & Johnson MedTech has hit its latest milestone, earning a significant regulatory nod for its ...
Abstract: Drug repositioning can effectively reduce research and development costs and accelerate time to market by identifying new indications for existing drugs. In recent years, deep learning-based ...
Cataract surgery costs can add up, even with Medicare. Whitney Stidom of eHealth says Original Medicare Part B generally covers cataract removal and a traditional intraocular lens. After the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results